Century Therapeutics, Inc. (IPSC)

NCM – Real vaqt narxi. Valyuta: USD

2.02

-0.04 (-1.94%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

2.09

+0.07 (3.67%)

Bozordan keyin: Mar 27, 2026, 5:31 PM EDT

Kompaniya haqida

Century Therapeutics, Inc., biotexnologiya kompaniyasi, qattiq o'smalar, gematologik xavfli o'smalar va otoimmün kasalliklarni davolash uchun allogen hujayra terapiyalarini ishlab chiqish bilan shug'ullanadi. Uning asosiy mahsulot nomzodi CNTY-813 bo'lib, u iPSC dan olingan beta orolcha hujayralarini almashtirish terapiyasi bo'lib, 1-toifa diabetni davolash uchun Allo-Evasion 5.0 bilan ishlab chiqilgan. Kompaniya, shuningdek, B-hujayralari vositasida yuzaga keladigan otoimmün kasalliklarni davolash uchun Allo-Evasion 5.0 bilan ishlab chiqilgan CD19-ga yo'naltirilgan CD4+/CD8+ CAR-iT hujayra terapiyasi bo'lgan CNTY-308; va B-hujayralari vositasida yuzaga keladigan otoimmün kasalliklarni davolash uchun CD19 CAR ni ifoda qilish uchun ishlab chiqilgan oltita aniq gen tahriri bilan iPSC dan olingan allogen CAR-iNK hujayra terapiyasi bo'lgan CNTY-101ni ishlab chiqish bilan shug'ullanadi. Allo-Evasion 1.0 tahrirlari bilan. Century Therapeutics, Inc. 2018 yilda ro'yxatga olingan va shtab-kvartirasi Filadelfiyada, Pensilvaniya shtatida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Brent Pfeiffenberger M.B.A., Pharm.D.	President, CEO & Chairman
Dr. Chad A. Cowan Ph.D.	Chief Scientific Officer
Dr. Gregory Russotti Ph.D.	Chief Technology & Manufacturing Officer
Michael Naso Ph.D.	Senior VP of Cell Engineering
Mr. Douglas Carr CPA	Senior VP of Finance & Operations, Principal Financial Officer and Secretary
Ms. Elizabeth Devlin	VP & Head of Development
Ms. Megan Bilson	Chief People Officer